ArticleJAMA psychiatry2026
Predicting US Army Soldier Suicide-Related Behaviors at the Time of Periodic Health Assessments.
Article in JAMA psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors.
Funding
Abstract
Importance: Suicide is the leading cause of death among active-duty US Army soldiers. Evidence-based preventive interventions exist but need to be targeted to be cost-effective. Objectives: To develop machine learning models using administrative data available during periodic health assessments (PHAs) to determine eligibility for a remote group dialectical behavior therapy-based skills training intervention for soldiers with elevated risk of suicide or nonfatal suicide attempt. Design, Setting, and Participants: From regular US Army soldier PHAs completed from 2015 to 2019, separate 70% training samples were created for suicides and SAs. Each training sample contained all cases and a stratified equal-probability sample of 10 times as many controls, with inverse-probability of selection weights applied to controls. Model performance was evaluated in the remaining 30% test sample. Data analysis was conducted September 2025 through January 2026. Main Outcomes and Measures: Suicides were recorded in the National Death Index for soldiers either still in or out of active service. SAs were recorded in US Army records only for soldiers still in active service. A 24-month risk horizon was used because successive PHAs, though designed to occur annually, are sometimes separated by this much time. A loss to follow-up weight was used in the SA model to adjust for leaving service within 24 months. Results: PHA data were available from 668 684 regular US Army soldiers. A total of 1 932 243 PHAs (including 85.5% by male soldiers, 46.7% by soldiers aged 28 years or older, and 58.1% by married soldiers) completed during the 2015 to 2019 period were included in analyses. Over 24 months, suicide prevalence was 66.7 per 100 000 (SE = 3.6) and SA prevalence was 704.1 per 100 000 (SE = 14.7) adjusted for loss to follow-up. Test sample area under the receiver operating characteristic curve (AUROC) for suicide was 0.72 (SE = 0.17), with Integrated Calibration Index (ICI) of 0.0003 and Brier score of 0.0007. Test sample AUROC for SA was 0.81 (SE = 0.02), with ICI of 0.0014 and Brier score of 0.0070. Suicide prevalence was meaningfully elevated (at least twice that expected by chance) only in the 5% of PHAs with highest predicted risk (sensitivity = 18.6%; SE = 2.0%). SA risk was elevated only in the 10% of PHAs with highest predicted risk (sensitivity = 46.5%; SE = 1.0%). Predicted probabilities of suicide and SA were correlated (Pearson r = 0.29; t = 233.8; P < .001). Overall, 11.9% of PHAs revealed US Army soldiers at elevated risk of either suicide or SA, and 3.1% were at elevated risk of both outcomes. Conclusions and Relevance: Results of this prognostic study suggest that as suicides and SAs have distinct predictors, an attempt to optimize resource allocation will require thoughtful postintervention considerations of costs and benefits of interventions to optimize net benefit.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.